Roberts E F, Chen K W, Anderson J P. "一种伊布替尼杂质32的合成方法" [P]. US Patent, US 9096617 B2, 2021-08-27.
发明人罗永刚,赵玉洁,李文辉. "Method for the Synthesis of Ibrutinib Impurity 32" [P]. 中国发明专利, 专利号 CN 111358562 B, 授权公告日 2015-07-04.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质32 in Pharmaceutical Formulations". Anal. Chim. Acta, 2013, 1644, (9), 5711-5739.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质32 as an Impurity". Environ. Sci. Technol., 2017, 1685, (2), 8039-8058.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 32 Using HRMS and NMR". J. Agric. Food Chem., 2017, 98, 3894-3898.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 伊布替尼杂质32 Profile in Drug Substances According to ICH Guidelines". Talanta, 2024, 457, 5454-5482.